Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding.

Objectives:Pregnant/lactating women in some sub-Saharan Africa settings are at substantial risk of HIV acquisition and could benefit from preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF), but safety data in pregnancy/lactation are limited.Design:Systematic data review through